BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21485870)

  • 21. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
    Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
    Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs.
    Alotaibi A; Bhatnagar P; Najafzadeh M; Gupta KC; Anderson D
    Nanomedicine (Lond); 2013 Mar; 8(3):389-401. PubMed ID: 22943128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-polymer nanoparticles encapsulating doxorubicin and 2'-deoxy-5-azacytidine enhance the sensitivity of cancer cells to chemical therapeutics.
    Su X; Wang Z; Li L; Zheng M; Zheng C; Gong P; Zhao P; Ma Y; Tao Q; Cai L
    Mol Pharm; 2013 May; 10(5):1901-9. PubMed ID: 23570548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
    Liu J; Qiu Z; Wang S; Zhou L; Zhang S
    Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted biodegradable nanoparticles for drug delivery to smooth muscle cells.
    Kona S; Specht D; Rahimi M; Shah BP; Gilbertson TA; Nguyen KT
    J Nanosci Nanotechnol; 2012 Jan; 12(1):236-44. PubMed ID: 22523971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of plant biocomposites based on Georgian tea "per se" and in combination with cisplatin on Walker carcinosarcoma W-256 and Guerin's carcinoma growth rate in rats].
    Zalietok SP; Orlovs'kyĭ OA; Hohol' SV; Samoĭlenko OA; Hulua L; Kvesitadze HI
    Lik Sprava; 2006 Dec; (8):89-93. PubMed ID: 17427433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly (lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target.
    Bhattacharyya SS; Paul S; De A; Das D; Samadder A; Boujedaini N; Khuda-Bukhsh AR
    Toxicol Appl Pharmacol; 2011 Jun; 253(3):270-81. PubMed ID: 21549736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.
    Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA
    Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
    Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
    Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.
    Tan S; Sasada T; Bershteyn A; Yang K; Ioji T; Zhang Z
    Nanomedicine (Lond); 2014 Apr; 9(5):635-47. PubMed ID: 23905577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
    Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.
    Verma RK; Pandya S; Misra A
    J Biomed Nanotechnol; 2011 Feb; 7(1):118-20. PubMed ID: 21485832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of rMETase-Loaded Stealth PLGA/Liposomes Modified with Anti-CAGE scFV for Treatment of Gastric Carcinoma.
    Xin L; Caot JQ; Liu C; Zeng F; Cheng H; Hu XY; Shao JH
    J Biomed Nanotechnol; 2015 Jul; 11(7):1153-61. PubMed ID: 26307838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal or nanoparticle alpha-TEA reduced 66cl-4 murine mammary cancer burden and metastasis.
    Wang P; Jia L; Sanders BG; Kline K
    Drug Deliv; 2007 Nov; 14(8):497-505. PubMed ID: 18027179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
    Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
    J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of osteoinduction by continual simvastatin release from poly(lactic-co-glycolic acid)-hydroxyapatite-simvastatin nano-fibrous scaffold.
    Jiang L; Sun H; Yuan A; Zhang K; Li D; Li C; Shi C; Li X; Gao K; Zheng C; Yang B; Sun H
    J Biomed Nanotechnol; 2013 Nov; 9(11):1921-8. PubMed ID: 24059091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.